Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution

per YAMAGUCHI, KEIZO, OGATA, YUTAKA, AKAGI, YOSHITO, SHIROUZU, KAZUO
Publicat 2013

Circulating endothelial progenitor cells in metronomic chemotherapy using irinotecan and/or bevacizumab for colon carcinoma: Study of their clinical significance

per MURAKAMI, HIDETSUGU, OGATA, YUTAKA, AKAGI, YOSHITO, ISHIBASHI, NOBUYA, SHIROUZU, KAZUO
Publicat 2011

Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells

per USHIJIMA, MASATAKA, OGATA, YUTAKA, TSUDA, HIDEAKI, AKAGI, YOSHITO, MATONO, KEIKO, SHIROUZU, KAZUO
Publicat 2014

Histocompatibility Leukocyte Antigen‐A2402‐restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor‐infiltrating Lymphocytes of Patients with Colon Cancer

per Gohara, Rumi, Nakao, Masanobu, Ogata, Yutaka, Isomoto, Hiroharu, Oizumi, Kotaro, Itoh, Kyogo
Publicat a Jpn J Cancer Res (1997)

Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal...

per Ogata, Yutaka, Matono, Keiko, Tsuda, Hideaki, Ushijima, Masataka, Uchida, Shinji, Akagi, Yoshito, Shirouzu, Kazuo
Publicat a PLoS One (2015)

Preventive effects of amino-acid-rich elemental diet Elental(®) on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study

per Ogata, Yutaka, Ishibashi, Nobuya, Yamaguchi, Keizou, Uchida, Shinji, Kamei, Hideki, Nakayama, Goichi, Hirakawa, Hiroaki, Tanigawa, Masahiko, Akagi, Yoshito
Publicat a Support Care Cancer (2015)

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

per Ogata, Yutaka, Tanaka, Takaho, Akagi, Yoshito, Ishibashi, Nobuya, Tsuji, Yoshiaki, Matono, Keiko, Isobe, Makoto, Sueyoshi, Susumu, Kaibara, Atsushi, Shirouzu, Kazuo
Publicat 2013

An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal can...

per Matsuoka, Hiroshi, Ogata, Yutaka, Nakamura, Michio, Shibata, Yoshihisa, Munemoto, Yoshinori, Bando, Hiroyuki, Nishijima, Koji, Okuda, Hiroyuki, Terada, Itsuro, Shiroiwa, Takeru, Kishimoto, Junji, Maeda, Kotaro
Publicat a J Anus Rectum Colon (2020)

A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

per Ogata, Yutaka, Shimokawa, Mototsugu, Tanaka, Takaho, Emi, Yasunori, Oki, Eiji, Saeki, Hiroshi, Sadanaga, Noriaki, Kusumoto, Tetsuya, Touyama, Tetsuo, Kimura, Masami, Baba, Hideo, Akagi, Yoshito, Shirouzu, Kazuo, Maehara, Yoshihiko
Publicat a Int J Clin Oncol (2015)

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage...

per Yoshino, Takayuki, Kotaka, Masahito, Shinozaki, Katsunori, Touyama, Tetsuo, Manaka, Dai, Matsui, Takanori, Ishigure, Kiyoshi, Hasegawa, Junichi, Inoue, Keiji, Munemoto, Yoshinori, Takagane, Akinori, Ishikawa, Hiroshi, Ishida, Hideyuki, Ogata, Yutaka, Oba, Koji, Goto, Koichi, Sakamoto, Junichi, Maehara, Yoshihiko, Ohtsu, Atsushi
Publicat a Cancer Chemother Pharmacol (2019)

Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study

per Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro
Publicat a Oncotarget (2015)

Erratum: Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study

per Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro
Publicat a Oncotarget (2015)